Phibro Animal Health Corporation
PAHC
$33.26
-$0.20-0.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 15.06% | 762.14% | 280.32% | 2,190.43% | 148.42% |
| Total Depreciation and Amortization | -1.33% | 11.38% | 42.49% | 41.53% | 37.19% |
| Total Amortization of Deferred Charges | 0.00% | 13.49% | 55.86% | 17.51% | 120.00% |
| Total Other Non-Cash Items | 792.25% | -36.17% | 151.28% | 298.54% | -82.76% |
| Change in Net Operating Assets | -416.91% | -41.77% | -1,813.02% | -168.22% | 182.07% |
| Cash from Operations | -62.45% | 529.13% | -26.30% | -25.17% | 278.28% |
| Capital Expenditure | -97.73% | -41.87% | -44.07% | -0.54% | 20.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -2,493.18% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 84.24% | -115.95% | -208.34% | -80.84% | -187.38% |
| Cash from Investing | 7.92% | 93.40% | -617.20% | 22.80% | -1,715.13% |
| Total Debt Issued | -9.88% | -87.11% | -84.83% | -52.30% | 25.20% |
| Total Debt Repaid | 35.00% | 61.91% | 88.85% | 47.25% | -85.36% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.06% | -0.08% | -0.08% | -0.06% | -0.10% |
| Other Financing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Financing | 92.86% | -106.87% | 155.95% | -534.58% | -763.84% |
| Foreign Exchange rate Adjustments | 290.50% | 87.22% | -85.32% | 269.18% | 537.96% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 91.71% | -213.43% | 125.19% | -62.31% | -138.95% |